Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma

Zhao-Qu Li, Lan Zou, Tian-Run Liu and An-Kui Yang
Cancer Biology & Medicine December 2015, 12 (4) 394-400; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0043
Zhao-Qu Li
1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China
2Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lan Zou
1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China
2Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tian-Run Liu
3Department of Otorhinolaryngology Head and Neck Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
An-Kui Yang
1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China
2Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

Objective: Patients with head and neck cancer often suffer from malnutrition. This study aims to investigate the influence of body mass index (BMI) on the prognosis of laryngeal squamous cell carcinoma (LSCC).

Methods: A total of 473 patients with LSCC initially treated at Sun Yat-sen University Cancer Center between January 2005 and July 2009 were retrospectively reviewed. Survival analysis was performed by the Kaplan-Meier method and Cox regression model.

Results: Low BMI before treatment was significantly associated with poor overall survival in patients with LSCC (P<0.001). BMI was an independent prognostic factor for patients with LSCC.

Conclusion: Leanness before treatment was associated with poor prognosis in patients with LSCC. Good nutritional status is favorable to improve survival in patients with LSCC.

keywords

  • Prognosis
  • nutrition
  • body mass index (BMI)
  • laryngeal squamous cell carcinoma (LSCC)

Introduction

Head and neck cancer is the sixth most common cancer worldwide, and the most common malignancy of the head and neck is laryngeal squamous cell carcinoma (LSCC)1,2. This disease often involves male patients older than 50 years old. LSCC seriously affects the life quality of patients, and the 5-year survival is about 60% regardless of stage, treatment strategy, and tumor location1,3.

Several factors are associated with the prognosis of LSCC, including smoking and alcohol consumption, human papillomavirus and Epstein-Barr virus infections, radiation, and heredity1,2. Patients with head and neck cancer often suffer from malnutrition. Nutritional status has been reported to be associated with risk4 and survival in several types of head and neck cancer, such as oral5–7 and pharyngeal cancers8. Understanding the prognostic value of nutritional status in patients with LSCC bears clinical significance.

Body mass index (BMI), a measure of relative weight based on the mass and height of an individual, is widely used to evaluate nutritional status. BMI has been identified as a possible risk factor for several cancers. Several studies have suggested that high BMI indicates a significantly better prognosis than low BMI for patients with oral cavity and oropharyngeal cancer5,6,8,9, whereas other researchers reported conflicting results7. However, the influence of BMI on the prognosis of head and neck cancer, including LSCC, remains controversial. In the present study, we investigated the prognostic influence of BMI on LSCC.

Materials and methods

Patients and follow up

We retrospectively reviewed 473 patients diagnosed with LSCC and initially treated at Sun Yat-sen University Cancer Center (SYSUCC) between January 2005 and July 2009. The patients consisted of 456 males (96%) and 17 females (4%). Their ages ranged from 24 to 86 years (median, 59 years). The clinical characteristics of the patients are summarized in Table 1. No patient had distant metastasis prior to treatment. Among the 473 patients, 430 underwent surgery, 17 received chemotherapy and radiation treatment after surgery, 32 received radiotherapy, and 21 received chemotherapy after surgery. Surgical margins were free of disease.

View this table:
  • View inline
  • View popup
1

Association of BMI status with the clinical characteristics of patients with LSCC

Of the 43 patients who did not undergo surgery, 11 received radiation treatment, 22 underwent chemotherapy, and 10 underwent both chemotherapy and radiation treatment.

The survival time was defined as the period from the date of the initial treatment to the date of death or final follow up (July 2014). This study followed the Declaration of Helsinki on medical protocol and ethics, and it was approved by the Institutional Review Board at SYSUCC. Written informed consent was obtained from all patients for the publication of this study.

Criteria for nutritional status

The nutritional status of the patients was classified by BMI in accordance with Asian-specific BMI cutoff points as follows: overweight (≥25 kg/m2), normal weight (≥18.5 and <25 kg/m2), or underweight (<18.5 kg/m2)10. The BMI data were obtained before treatment.

Statistical analysis

The Chi-square test and Kruskal-Wallis H test were used for bivariate analysis. Kaplan-Meier and log-rank tests were used for survival analysis. Multivariate Cox regression analysis was performed for significant variables found using univariate analysis. SPSS 16.0 was used for all analyses. P<0.05 was considered statistically significant.

Results

Patient characteristics and bivariate analysis

A total of 473 patients participated in this study. The clinicopathological characteristics of the patients are summarized in Table 1. Among the 473 patients, 83 (17%) were underweight, 296 (63%) were of normal weight, and 94 (20%) were overweight based on their BMI. The groups of patients with different BMI statuses showed similar distributions of host and tumor factors, including age, gender, smoking and alcohol intake, and pathology grade. Patients with low BMI showed a high incidence of advanced T stage (47.0% vs. 32.5% vs. 24.5%, P=0.029) and N stage (25.3% vs. 11.8% vs. 9.6%, P<0.001; Table 1).

All patients were divided into the survival and non-survival groups. The survival group consisted of 332 patients (70%), and the non-survival group comprised 141 patients (30%). The bivariate analysis of factors between the groups is presented in Table 2. The two groups showed significant differences in age, smoking and alcohol intake, T stage, N stage, pathology grade, treatment strategy, tumor location, and BMI status. However, no significant difference was found in gender between the two groups.

View this table:
  • View inline
  • View popup
2

Bivariate descriptive analysis of patients with LSCC

Prognostic value of BMI

The overall 5-year survival rate of these patients was 72.3%. Figure 1 reveals that the underweight patients had the lowest survival, whereas the overweight patients had the best survival (P<0.001). The 5-year overall survival rates of the overweight group, normal weight group, and underweight group were 87.2%, 78.0%, and 34.9%, respectively. The median survival time of the underweight group was 29.6 months.

1
  • Download figure
  • Open in new tab
  • Download powerpoint
1

Kaplan-Meier curves for overall survival according to BMI.

The Cox proportional hazards model was used to verify whether the BMI status and other variables are independent prognostic factors for LSCC patients. Univariate analysis showed that age, history of smoking and alcohol intake, T stage, N stage, pathology grade, tumor location, treatment strategy, and BMI were associated with survival in patients with LSCC. Multivariate analysis of these variables showed that age, history of smoking and alcohol intake, T stage, N stage, pathology grade, treatment strategy, and BMI were independent prognostic factors for patients with LSCC, and low BMI was significantly associated with poor prognosis (Table 3).

View this table:
  • View inline
  • View popup
3

Univariate and multivariate Cox regression analysis for overall survival in patients with LSCC

Discussion

Our study demonstrated that BMI was significantly associated with the prognosis of LSCC, and low BMI before treatment predicted poor prognosis in patients with LSCC.

Malnutruitional status is reportedly associated with poor prognosis in several types of cancers4-8,11. In these studies, leanness was found to be associated with increased risk for head and neck cancer regardless of the smoking and drinking status, and it was reported as an early marker of oral and pharyngeal cancer4-8. For example, oral cancer patients with a BMI <22.8 kg/m2 have poor prognosis, and weight loss can predict poor prognosis in recurrent oral and oropharyngeal carcinoma5,6. A previous retrospective analysis reported that patients with head and neck cancer and preoperative weight loss greater than 5% show poor outcome11. Notably, a study by Iyengar et al.7 indicated that obesity is an independent predictor of increased risk of death for patients with early-stage oral tongue cancer. These conflicting results may be due to an inadequate sample size and inconsistent BMI cutoff values. These studies also found various tumor sites in the oral cavity, oropharynx, and larynx with various types of histopathology. In the current study, a total of 473 patients diagnosed with LSCC were analyzed, and the patients were classified according to Asian-specific BMI cutoff values. We found that low BMI was significantly associated with poor survival in LSCC, which was in agreement with previous data.

Malnutrition commonly occurs in patients with head and neck cancer, particularly in laryngeal cancer, which seriously affects the quality of life and nutritional status of the patient. Thus, weight loss before treatment is associated with poor prognosis. In China, underweight patients are associated with low income and education. These patients are less likely to receive proper treatment at an early stage. In addition, good nutritional status can improve survival by strengthening immunity and helping patients develop a high tolerance for extended therapeutic periods. However, our conclusion requires further demonstration. We found that patients with low BMI showed an increased incidence of advanced T and N stages, which may also contribute to decreased survival in patients with low BMI.

The present study demonstrated that patients over 60 years old exhibited low survival rates. Aging patients with oral tongue cancer have been reported to have high disease-specific mortality12. This finding suggested increased vulnerability to deterioration of nutritional or physical status among old patients. Heavy tobacco and alcohol consumption were determined to be adverse prognostic factors in patients with head and neck cancer, including laryngeal cancer13. Another study identified heavy alcohol consumption as a risk factor for malnutrition14. Postoperative complications have also been reported to be associated with poor prognosis in patients with oral cancer15. The present study found similar factors that could contribute to the advanced disease stage or poor general condition, both of which could increase the risk of developing complications. Developing complications would inevitably delay the administration of standard therapy, leading to recurrence or distal metastasis. Recurrence or distal metastasis may negatively affect initial treatment. Consequently, patients with low BMI have poor prognosis5.

The molecular and cellular mechanisms by which BMI affects the prognosis of cancer are complicated and unclear. Several studies have shown that a specific enteral nutrition formula containing n-3 fatty acid can prevent the deterioration of nutritional status during chemoradiation therapy for head and neck cancer; triglycerides have also been reported to promote cancer cell proliferation, and this anti-apoptotic activity is probably due to the generation of reactive oxygen species and oxidative stress, which leads to DNA damage16,17. Levels of adipokine, leptin, and adiponectin influence obesity and several signal transduction pathways involved in cell survival18. Another study reported that obesity induces insulin-resistance through the accumulation of macrophages that secrete inflammatory mediators, such as tumor necrosis factor-α, interleukin-6, and prostaglandin E219. The insulin receptor activating signaling pathways are also associated with invasion and metastasis of malignant tumors20. However, the mechanisms require further study.

Conclusion

Our study proved that BMI was an independent prognostic factor for patients with LSCC, and low BMI before treatment could predict poor prognosis for patients with LSCC. Good nutritional status could improve survival in patients with LSCC. However, our study was limited by the retrospective design. Thus, further studies are necessary to verify the correlation between BMI and the prognosis of LSCC.

Acknowledgements

This work was supported by the Science and Technology Planning Project of Guangdong Province, China (Grant No. 2010B031600237).

Footnotes

  • ↵* These authors have contributed equally to this work.

  • Conflict of interest statement No potential conflicts of interest are disclosed.

  • Received June 5, 2015.
  • Accepted September 21, 2015.
  • Copyright: © 2015, Cancer Biology & Medicine
https://creativecommons.org/licenses/by/4.0/

This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

References

  1. 1.↵
    1. Markou K,
    2. Christoforidou A,
    3. Karasmanis I,
    4. Tsiropoulos G,
    5. Triaridis S,
    6. Constantinidis I, et al.
    Laryngeal cancer: epidemiological data from Northern Greece and review of the literature. Hippokratia 2013;17:313–318.
    OpenUrl
  2. 2.↵
    1. De Stefani E,
    2. Boffetta P,
    3. Deneo-Pellegrini H,
    4. Brennan P,
    5. Correa P,
    6. Oreggia F, et al.
    Supraglottic and glottic carcinomas: epidemiologically distinct entities? Int J Cancer 2004;112:1065–1071.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Machiels JP,
    2. Lambrecht M,
    3. Hanin FX,
    4. Duprez T,
    5. Gregoire V,
    6. Schmitz S, et al.
    Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep 2014;6:44.
    OpenUrl
  4. 4.↵
    1. Gaudet MM,
    2. Olshan AF,
    3. Chuang SC,
    4. Berthiller J,
    5. Zhang ZF,
    6. Lissowska J, et al.
    Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol 2010;39:1091–1102.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Liu SA,
    2. Tsai WC,
    3. Wong YK,
    4. Lin JC,
    5. Poon CK,
    6. Chao SY, et al.
    Nutritional factors and survival of patients with oral cancer. Head Neck 2006;28:998–1007.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Nguyen TV,
    2. Yueh B.
    Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer 2002;95:553–562.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Iyengar NM,
    2. Kochhar A,
    3. Morris PG,
    4. Morris LG,
    5. Zhou XK,
    6. Ghossein RA, et al.
    Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue. Cancer 2014;120:983–991.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Franceschi S,
    2. Dal Maso L,
    3. Levi F,
    4. Conti E,
    5. Talamini R,
    6. La Vecchia C.
    Leanness as early marker of cancer of the oral cavity and pharynx. Ann Oncol 2001;12:331–336.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Takenaka Y,
    2. Takemoto N,
    3. Nakahara S,
    4. Yamamoto Y,
    5. Yasui T,
    6. Hanamoto A, et al.
    Prognostic significance of body mass index before treatment for head and neck cancer. Head Neck 2015;37:1518–1523.
    OpenUrl
  10. 10.↵
    1. Choi Y,
    2. Park B,
    3. Jeong BC,
    4. Seo SI,
    5. Jeon SS,
    6. Choi HY, et al.
    Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 2013;132:625–634.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. van Bokhorst-de van der Schuer,
    2. van Leeuwen PA,
    3. Kuik DJ,
    4. Klop WM,
    5. Sauerwein HP,
    6. Snow GB, et al.
    The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999;86:519–527.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Davidson BJ,
    2. Root WA,
    3. Trock BJ.
    Age and survival from squamous cell carcinoma of the oral tongue. Head Neck 2001;23:273–279.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Reyes-Gibby CC,
    2. Anderson KO,
    3. Merriman KW,
    4. Todd KH,
    5. Shete SS,
    6. Hanna EY.
    Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain 2014;15:1015–1022.
    OpenUrlPubMed
  14. 14.↵
    1. Righini CA,
    2. Timi N,
    3. Junet P,
    4. Bertolo A,
    5. Reyt E,
    6. Atallah I.
    Assessment of nutritional status at the time of diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2013;130:8–14.
    OpenUrl
  15. 15.↵
    1. de Melo GM,
    2. Ribeiro KC,
    3. Kowalski LP,
    4. Deheinzelin D.
    Risk factors for postoperative complications in oral cancer and their prognostic implications. Arch Otolaryngol Head Neck Surg 2001;127:828–833.
    OpenUrlPubMed
  16. 16.↵
    1. Fietkau R,
    2. Lewitzki V,
    3. Kuhnt T,
    4. Hölscher T,
    5. Hess CF,
    6. Berger B, et al.
    A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer 2013;119:3343–3353.
    OpenUrlPubMed
  17. 17.↵
    1. Cowey S,
    2. Hardy RW.
    The metabolic syndrome: A high-risk state for cancer? Am J Pathol 2006;169:1505–1522.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. van Kruijsdijk RC,
    2. van der Wall E,
    3. Visseren FL.
    Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:2569–2578.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Olefsky JM,
    2. Glass CK.
    Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219–246.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Penaranda EK,
    2. Shokar N,
    3. Ortiz M.
    Relationship between metabolic syndrome and history of cervical cancer among a US national population. ISRN Oncol 2013;2013:840964.
    OpenUrl
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 12 (4)
Cancer Biology & Medicine
Vol. 12, Issue 4
1 Dec 2015
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma
Zhao-Qu Li, Lan Zou, Tian-Run Liu, An-Kui Yang
Cancer Biology & Medicine Dec 2015, 12 (4) 394-400; DOI: 10.7497/j.issn.2095-3941.2015.0043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma
Zhao-Qu Li, Lan Zou, Tian-Run Liu, An-Kui Yang
Cancer Biology & Medicine Dec 2015, 12 (4) 394-400; DOI: 10.7497/j.issn.2095-3941.2015.0043
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier
  • Nuclear PHGDH regulates macrophage polarization through transcriptional repression of GLUD1 and GLS2 in breast cancer
  • Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis
Show more Original Article

Similar Articles

Keywords

  • prognosis
  • nutrition
  • body mass index (BMI)
  • laryngeal squamous cell carcinoma (LSCC)

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire